Instil Bio (TIL) Exchange Rate Effect (2020 - 2026)
Instil Bio (TIL) posted quarterly Exchange Rate Effect of -$5000.0 for Q1 2026, down 111.63% year-over-year from $43000.0 in Q1 2025, and up 73.68% quarter-over-quarter from -$19000.0 in Q4 2025.
Instil Bio (TIL) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Instil Bio's Exchange Rate Effect history runs 7 years deep, the most recent figure standing at -$5000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 111.63% year-over-year to -$5000.0; the TTM figure through Mar 2026 stood at -$28000.0 (down 333.33% YoY), while the FY2025 annual figure was $20000.0, up 121.28% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$5000.0, up from -$19000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $729000.0 in Q1 2022, with the low at -$873000.0 in Q2 2022.
- The 5-year median for Exchange Rate Effect is -$19000.0 (2023), against an average of -$53941.2.
- Peak annual rise in Exchange Rate Effect reached 834.62% in 2022, while the deepest fall reached 529.77% in 2022.
- Instil Bio's Exchange Rate Effect stood at $70000.0 in 2022, then tumbled by 127.14% to -$19000.0 in 2023, then slumped by 242.11% to -$65000.0 in 2024, then jumped by 70.77% to -$19000.0 in 2025, then surged by 73.68% to -$5000.0 in 2026.
- Business Quant data shows TIL's Exchange Rate Effect at -$5000.0 in Q1 2026, -$19000.0 in Q4 2025, and -$25000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Instil Bio | 53.44 Mn | 53.44 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Sep 30, 2025 | -25,000.00 |
| Sep 30, 2025 | -25,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -63,000.00 |
| Mar 31, 2024 | -63,000.00 |